Nov 13th, 2020

TIPS-3 + ASA results

Principal investigator Salim Yusuf, MBBS, Dphil, summarizes the results of TIPS-3 ASA

Principal investigator Salim Yusuf, MBBS, Dphil, summarizes the results of TIPS-3 ASA, which tested the use of a polypill plus aspirin for the primary prevention of cardiovascular disease and death. See abstracts and more Scientific Sessions 2020 presentations.

Audience shot

Late-breaking science| Achieving equity in prevention

audience shot

Novel mechanisms for lipid-lowering therapy

LBS 08 panelists

Late-breaking science: AI at the bedside

Lbs05 Panel Web

Shocking decisions in AFib care

Lbs04 Panel2 Web

Drugs, diet and delivery can optimize hypertension outcomes

audience shot

Heart failure late-breaking science

A. Michael Lincoff, MD

Weight-loss drug reduced secondary CV risk in people with overweight or obesity without diabetes

From left: Christopher Rajkumar, MD, MRC, Jeffrey L. Carson, MD, MACP; Stefan James, MD.

Trials’ results suggest new approaches to reducing CVD risk and symptoms

AHA audience

Late-Breaking Science announced

audience

Early ablation bests medication in treatment naïve AFib patients

audience shot

First-in-class aminopeptidase-A inhibitor fails to reduce treatment-resistant hypertension

audience shot

Trial results shed light on tool for assessing VTE risk, routine anticoagulation for non-hospitalized COVID patients, and clinical outcomes of open vs. endovascular surgery for advanced PAD